Stifel lowered the firm’s price target on Thermo Fisher (TMO) to $620 from $665 and keeps a Buy rating on the shares. Thermo “performed well” in Q1 and the company looks to be in good shape to manage through end market and tariff headwinds effectively, though policy changes being pushed “will be tangible when it comes to the P&L,” the analyst tells investors in a post-earnings note.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher price target lowered to $637 from $651 at RBC Capital
- Thermo Fisher price target lowered to $573 from $603 at Baird
- Thermo Fisher’s Resilience and Strategic Positioning Justify Buy Rating Despite Macroeconomic Challenges
- Thermo Fisher Scientific Reports Strong Q1 2025 Results
- Thermo Fisher Scientific Navigates Strong Q1 Amid Challenges
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue